Using AI to accelerate biomarker driven drug discovery in Glioblastoma: a proof of concept for the `gbm.code¿ platform using arrayed phenotypic CRISPRi screening.

Project Details

StatusActive
Effective start/end date1/03/2228/02/23

Funding

  • UK-based charities: £18,157.00